Abstract
Last November, the country's foremost experts on biological cancer therapy gathered in historic Williamsburg, VA, for the “Second Conference on Immunity to Cancer.” Bio/Technology senior editor Arthur Klausner took the opportunity to roust several of these sages out of bed early one morning for an eye–opening breakfast roundtable discussion focusing on the status and future direction of cancer biotherapy.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Rights and permissions
About this article
Cite this article
The Bio/Technology Roundtable on Cancer Biotherapy. Nat Biotechnol 6, 133–143 (1988). https://doi.org/10.1038/nbt0288-133
Issue Date:
DOI: https://doi.org/10.1038/nbt0288-133
